bioRxiv · 10.1101/106815
Accumulation of Minor Alleles of Common SNPs in Schizophrenia
Abstract
Schizophrenia is a common neuropsychiatric disorder with a lifetime risk of 1%. A number of large scale genome wide association studies have identified numerous individual risk single nucleotide polymorphisms (SNPs) whose precise roles in schizophrenia remain unknown. Accumulation of many of these risk alleles has been found to be a more important risk factor. Consistently, recent studies showed a role for enrichment of minor alleles (MAs) in complex diseases. Here we studied the role of MAs in general in schizophrenia using public datasets. Relative to matched controls, schizophrenia cases showed higher minor allele content (MAC), especially for the sporadic cases. By linkage analysis, we identified 82 419 SNPs that could be used to predict 2.2% schizophrenia cases with 100% certainty. Pathway enrichment analysis of these SNPs identified 17 pathways, 15 of which are known to be linked with Schizophrenia with the remaining 2 associated with other mental disorders. These results suggest a role for a collective effect of MAs in schizophrenia and provide a method to genetically screen for schizophrenia.\n\nAbbreviations
Source connections
Explore related subjects
Keep this discovery
He, P., Lei, X., Yuan, D., Zhu, Z., Huang, S.. 2017-02-08. Accumulation of Minor Alleles of Common SNPs in Schizophrenia. https://doi.org/10.1101/106815
Cite the original work for its findings. Save a collection to share your selection of sources.